Controlled Ovarian Stimulation — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for controlled ovarian stimulation. 155 active patents protecting 3 drugs from 3+ originators. First major cliff: 2028. Daily refresh.

3
Approved drugs
155
Active US patents
50/100
Avg vulnerability
—
Annual revenue covered

Originators in Controlled Ovarian Stimulation

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Pfizer 101 patents Exeltis Usa Inc 42 patents Fdn Consumer 12 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating controlled ovarian stimulation. Each bar = one year. Y-axis scaled to peak year (76 patents).

2
27
12
28
7
29
9
30
31
31
76
32
4
33
3
34
4
36
2
37
1
38
1
40

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Estrace
ESTRADIOL
 Pfizer 101 37 — 2028-07-10
Slynd
DROSPIRENONE
 Exeltis Usa Inc 42 64 — 2028-01-15
Jadelle
LEVONORGESTREL
 Fdn Consumer 12 48 — 2027-02-07

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
11951213 Slynd method of use 81 2031-06-28
11951213 Slynd method of use 81 2031-06-28
12090231 Slynd method of use 81 2031-06-28
12090231 Slynd method of use 81 2031-06-28
11617751 Slynd method of use 76 2030-07-17
11617751 Slynd method of use 76 2030-07-17
11413249 Slynd method of use 76 2031-06-28
10603281 Slynd method of use 76 2031-06-28
9603860 Slynd method of use 76 2031-06-28
10179140 Slynd method of use 76 2031-06-28

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
12004992 Jadelle composition of matter 0 2033-10-06
11795178 Estrace composition of matter 0 2033-09-27
12325714 Estrace composition of matter 0 2033-09-27
11865179 Estrace composition of matter 0 2032-11-21
11865179 Estrace composition of matter 0 2032-11-21
8231906 Estrace composition of matter 0 2030-07-04
8231906 Estrace composition of matter 0 2030-07-04
8231906 Estrace composition of matter 0 2030-07-04
8231906 Estrace composition of matter 0 2030-07-04
8231906 Estrace composition of matter 0 2030-07-04

Related